These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 16959926)

  • 1. Aripiprazole in the treatment of delirium.
    Straker DA; Shapiro PA; Muskin PR
    Psychosomatics; 2006; 47(5):385-91. PubMed ID: 16959926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An open trial of aripiprazole for the treatment of delirium in hospitalized cancer patients.
    Boettger S; Breitbart W
    Palliat Support Care; 2011 Dec; 9(4):351-7. PubMed ID: 22104410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aripiprazole and haloperidol in the treatment of delirium.
    Boettger S; Friedlander M; Breitbart W; Passik S
    Aust N Z J Psychiatry; 2011 Jun; 45(6):477-82. PubMed ID: 21563866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aripiprazole for the treatment of psychoses in institutionalized patients with Alzheimer dementia: a multicenter, randomized, double-blind, placebo-controlled assessment of three fixed doses.
    Mintzer JE; Tune LE; Breder CD; Swanink R; Marcus RN; McQuade RD; Forbes A
    Am J Geriatr Psychiatry; 2007 Nov; 15(11):918-31. PubMed ID: 17974864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjunctive low-dose aripiprazole with standard-dose sertraline in treating fresh major depressive disorder: a randomized, double-blind, controlled study.
    Lin CH; Lin SH; Jang FL
    J Clin Psychopharmacol; 2011 Oct; 31(5):563-8. PubMed ID: 21869699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Open-label aripiprazole in the treatment of acute bipolar depression: a prospective pilot trial.
    McElroy SL; Suppes T; Frye MA; Altshuler LL; Stanford K; Martens B; Leverich GS; Post RM; Keck PE
    J Affect Disord; 2007 Aug; 101(1-3):275-81. PubMed ID: 17229469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness and tolerability of aripiprazole in child and adolescent inpatients: a retrospective evaluation.
    Gibson AP; Crismon ML; Mican LM; Fischer C
    Int Clin Psychopharmacol; 2007 Mar; 22(2):101-5. PubMed ID: 17293710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time course of the changes in antipsychotic-induced hyperprolactinemia following the switch to aripiprazole.
    Lu ML; Shen WW; Chen CH
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Dec; 32(8):1978-81. PubMed ID: 18848860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aripiprazole, an antipsychotic with a novel mechanism of action, and risperidone vs placebo in patients with schizophrenia and schizoaffective disorder.
    Potkin SG; Saha AR; Kujawa MJ; Carson WH; Ali M; Stock E; Stringfellow J; Ingenito G; Marder SR
    Arch Gen Psychiatry; 2003 Jul; 60(7):681-90. PubMed ID: 12860772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patients with schizophrenia treated with aripiprazole, a multicentre naturalistic study.
    Christensen AF; Poulsen J; Nielsen CT; Bork B; Christensen A; Christensen M
    Acta Psychiatr Scand; 2006 Feb; 113(2):148-53. PubMed ID: 16423167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An open-label assessment of aripiprazole in the treatment of PTSD.
    Robert S; Hamner MB; Durkalski VL; Brown MW; Ulmer HG
    Psychopharmacol Bull; 2009; 42(1):69-80. PubMed ID: 19204652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychosis in the elderly.
    Kyomen HH; Whitfield TH
    Am J Psychiatry; 2009 Feb; 166(2):146-50. PubMed ID: 19188291
    [No Abstract]   [Full Text] [Related]  

  • 13. Efficacy and tolerability of aripiprazole augmentation in sertraline-resistant patients with borderline personality disorder.
    Bellino S; Paradiso E; Bogetto F
    Psychiatry Res; 2008 Nov; 161(2):206-12. PubMed ID: 18848360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Young mania rating scale line item analysis in pediatric subjects with bipolar I disorder treated with aripiprazole in a short-term, double-blind, randomized study.
    Mankoski R; Zhao J; Carson WH; Mathew SJ; Forbes RA
    J Child Adolesc Psychopharmacol; 2011 Aug; 21(4):359-64. PubMed ID: 21823911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of ziprasidone and aripiprazole in acutely ill patients with schizophrenia or schizoaffective disorder: a randomized, double-blind, 4-week study.
    Zimbroff D; Warrington L; Loebel A; Yang R; Siu C
    Int Clin Psychopharmacol; 2007 Nov; 22(6):363-70. PubMed ID: 17917555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aripiprazole in the treatment of delirium.
    Alao AO; Soderberg M; Pohl EL; Koss M
    Int J Psychiatry Med; 2005; 35(4):429-33. PubMed ID: 16673842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An open-label study of the efficacy and tolerability of aripiprazole for children and adolescents with tic disorders.
    Yoo HK; Choi SH; Park S; Wang HR; Hong JP; Kim CY
    J Clin Psychiatry; 2007 Jul; 68(7):1088-93. PubMed ID: 17685747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A 12-week randomized, open-label study of perospirone versus aripiprazole in the treatment of Japanese schizophrenia patients.
    Takekita Y; Kato M; Wakeno M; Sakai S; Suwa A; Nishida K; Okugawa G; Kinoshita T
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Jan; 40():110-4. PubMed ID: 23022672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term efficacy and safety of aripiprazole in patients with schizophrenia, schizophreniform disorder, or schizoaffective disorder: 26-week prospective study.
    Kwon JS; Jang JH; Kang DH; Yoo SY; Kim YK; Cho SJ;
    Psychiatry Clin Neurosci; 2009 Feb; 63(1):73-81. PubMed ID: 19154213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trial of aripiprazole in the treatment of first-episode schizophrenia.
    Lee HY; Ham BJ; Kang RH; Paik JW; Hahn SW; Lee MS; Lee MS
    Psychiatry Clin Neurosci; 2010 Feb; 64(1):38-43. PubMed ID: 20416024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.